Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 514,963 |
|
|||||
| News | - | ||||||
| Day High | 13.30 | Low High |
|||||
| Day Low | 12.48 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Nevro Corp | NVRO | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.28 | -2.19% | 12.51 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 12.83 | 12.48 | 13.30 | 12.51 | 12.79 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,131 | 514,963 | $ 12.81 | $ 6,598,795 | - | 11.98 - 34.86 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:00:00 | 44,704 | $ 12.51 | USD |
Nevro Corp Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 456.07M | 36.40M | - | 425.17M | -92.21M | -2.53 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Nevro News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NVRO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 12.63 | 13.30 | 11.98 | 12.35 | 414,120 | -0.12 | -0.95% |
| 1 Month | 13.73 | 14.70 | 11.98 | 12.97 | 415,977 | -1.22 | -8.89% |
| 3 Months | 16.80 | 17.75 | 11.98 | 14.70 | 453,282 | -4.29 | -25.54% |
| 6 Months | 15.87 | 22.64 | 11.98 | 16.78 | 539,743 | -3.36 | -21.17% |
| 1 Year | 33.11 | 34.86 | 11.98 | 19.85 | 532,037 | -20.60 | -62.22% |
| 3 Years | 166.37 | 182.45 | 11.98 | 55.55 | 545,493 | -153.86 | -92.48% |
| 5 Years | 63.58 | 188.14 | 11.98 | 76.01 | 490,002 | -51.07 | -80.32% |
Nevro Description
| Nevro Corp is a medical device company. Its key product is the Senza spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. Nevro generates the majority of its revenue in the United States. It also receives nearly half of its revenue from Australia, the United Kingdom, and Germany. |
